Eric A. Rose- "We shall say, product in -- that we've developed in smallpox. We have some earlier stage assets with regard to antiviral drug discovery that we think are partnerable. And we believe that a company with our existing assets now is in a very strong position to pursue multiple opportunities."
If the pre-clinical R&D department was paid for by government contracts and grants, then they eliminate it, they are no longer getting financial support from the gov. If this is the case seems they should have done a better job of informing the public they no longer receive this money.